Inventor · disambiguated record
Robert Hubbard
Also filed as: HUBBARD ROBERT · HUBBARD ROBERT D · HUBBARD ROBERT DALE
15 granted patents·12 pending applications·140 citations·filing 2000–2023
92Inventor score
Top patents by PatentIndex Score
27 records- 0197US9512124B2Substituted aminopurine compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2015·Granted Dec 6, 2016·32 cites·60 claims
- 0296US9737541B2Substituted aminopurine compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2016·Granted Aug 22, 2017·12 cites·52 claims
- 0394US7772231B2Substituted pyrazolo[3,4-d]pyrimidines as protein kinase inhibitorsABBOTT LAB·Filed 2006·Granted Aug 10, 2010·68 cites·20 claims
- 0488US10398700B2Substituted aminopurine compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2018·Granted Sep 3, 2019·2 cites·11 claims
- 0587US10149849B2Substituted aminopurine compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2017·Granted Dec 11, 2018·2 cites·3 claims
- 0685US10940152B2Substituted aminopurine compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2020·Granted Mar 9, 2021·1 cites·27 claims
- 0784US10646493B2Substituted aminopurine compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2019·Granted May 12, 2020·1 cites·20 claims
- 0884US2023158035A1Substituted aminopurine compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2023·Application pending·0 cites
- 0983US7812022B22-pyrimidinyl pyrazolopyridine ErbB kinase inhibitorsGLAXOSMITHKLINE LLC·Filed 2005·Granted Oct 12, 2010·8 cites·15 claims
- 1078US7807673B22-pyrimidinyl pyrazolopyridine ErbB kinase inhibitorsGLAXOSMITHKLINE LLC·Filed 2006·Granted Oct 5, 2010·7 cites·25 claims
- 1177US9561231B2Pyridinone and pyridazinone derivativesABBVIE INC·Filed 2013·Granted Feb 7, 2017·4 cites·43 claims
- 1276US9493411B2Pyrrole-3-carboxamide bromodomain inhibitorsABBVIE INC·Filed 2014·Granted Nov 15, 2016·3 cites·12 claims
- 1375US11590139B2Substituted aminopurine compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2021·Granted Feb 28, 2023·0 cites·52 claims
- 1462US2010063135A1Polyethylene glycol lipid conjugates and uses thereofABBOTT LAB·Filed 2009·Application pending·0 cites
- 1561US2010055168A1Cationic lipids and uses thereofABBOTT LAB·Filed 2009·Application pending·0 cites
- 1661US2010055169A1Cationic lipids and uses thereofABBOTT LAB·Filed 2009·Application pending·0 cites
- 1761US2009263407A1Cationic Lipids and Uses ThereofABBOTT LAB·Filed 2009·Application pending·0 cites
- 1854US2008269298A1Benzimidazol-1-YL-thiophene compounds for the treatment of cancerANDREWS CLARENCE W·Filed 2008·Application pending·0 cites
- 1953US2010104629A1Cationic lipids and uses thereofABBOTT LAB·Filed 2009·Application pending·0 cites
- 2052US2010099738A1Polyethylene glycol lipid conjugates and uses thereofABBOTT LAB·Filed 2009·Application pending·0 cites
- 2148US8067409B2Protein kinase inhibitorsBA-MAUNG NWE Y·Filed 2008·Granted Nov 29, 2011·0 cites·12 claims
- 2248US2010076055A1Cationic Lipids and Uses ThereofABBOTT LAB·Filed 2009·Application pending·0 cites
- 2348US2009285881A1Cationic lipids and uses thereofABBOTT LAB·Filed 2009·Application pending·0 cites
- 2447US2006074119A1Thiophene compoundsANDREWS CLARENCE W III·Filed 2003·Application pending·0 cites
- 2546US6562782B1Oligocycloalkanoid compounds and methods of useUNIV ROCHESTER·Filed 2000·Granted May 13, 2003·0 cites·52 claims
- 2642US2023045737A1Substituted isoindolinones as modulators of cereblon-mediated neo-substrate recruitmentVIVIDION THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2738US10576085B2Substituted aminopurine compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2017·Granted Mar 3, 2020·0 cites·22 claims
Join the waitlist — get patent alerts
Get an alert when Robert Hubbard files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →